Kondo Naoto

age:

69 years

appointments:

7 active

0 prior

primary industry:

Human health activities

about Kondo

Since 2022, Mr Naoto has been a director of 7 companies, the current directorship have a combined turnover of approximately £49.7m.

Combined Valuation

£259.4m

Combined Turnover

£49.7m

active directorships over time

company
turnover
valuation
start
end
status
role
cytocell limited£13.3m£86.5mApr 2022-OpenDirector
cytocell limited£13.3m£86.5mApr 2022-OpenDirector
oxford gene technology limited-£53.4mApr 2022-OpenDirector
oxford gene technology (operations) ltd£11.6m£16.5mApr 2022-OpenDirector
oxford gene technology (operations) ltd£11.6m£16.5mApr 2022-OpenDirector
oxford gene technology ip limited--Apr 2022-OpenDirector
oxford gene technology ip limited--Apr 2022-OpenDirector